4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-034257
Options or other derivatives
- Director acquired 25,789 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Imper Vera Director | 2022-06-01 | Grant or award · Stock Option (right to buy) | +25,789 | 25,789 | D | ||
Loading xslF345X03/doc4.xml…